1 |
|
Metabolism
|
2121 |
0.865 |
Genes names |
- Dihydroorotate Dehydrogenase (Quinone)
- NAD(P)H Quinone Dehydrogenase 1
- Sulfide Quinone Oxidoreductase
|
|
2 |
|
Regulation of expression of SLITs and ROBOs
|
462 |
0.706 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
- Sulfide Quinone Oxidoreductase
|
|
3 |
|
Apoptosis and Autophagy
|
185 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
4 |
|
Interactions between LOXL4 and oxidative stress pathway
|
18 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
5 |
|
Disulfiram Pathway, Pharmacodynamics (Dopaminergic neuron)
|
19 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
6 |
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
52 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
7 |
|
Platinum Pathway, Pharmacokinetics/Pharmacodynamics
|
29 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
8 |
|
NF-kappaB Signaling
|
327 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
9 |
|
Oxidative stress response
|
32 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
10 |
|
Phenytoin Pathway, Pharmacokinetics
|
31 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
11 |
|
Benzene metabolism
|
5 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
12 |
|
Nuclear receptors meta-pathway
|
315 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
13 |
|
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling
|
23 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
14 |
|
Cellular responses to stimuli
|
802 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
15 |
|
Doxorubicin Pathway, Pharmacokinetics
|
28 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
16 |
|
Warfarin Pathway, Pharmacodynamics
|
18 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
17 |
|
Metabolism of nucleotides
|
99 |
0.499 |
Genes names |
- Dihydroorotate Dehydrogenase (Quinone)
|
|
18 |
|
Validated transcriptional targets of TAp63 isoforms
|
54 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
19 |
|
UMP biosynthesis
|
3 |
0.499 |
Genes names |
- Dihydroorotate Dehydrogenase (Quinone)
|
|
20 |
|
Sulfur amino acid metabolism
|
30 |
0.499 |
Genes names |
- Sulfide Quinone Oxidoreductase
|
|
21 |
|
Nuclear events mediated by NFE2L2
|
199 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
22 |
|
Pyrimidine metabolism and related diseases
|
20 |
0.499 |
Genes names |
- Dihydroorotate Dehydrogenase (Quinone)
|
|
23 |
|
Pyrimidine metabolism
|
85 |
0.499 |
Genes names |
- Dihydroorotate Dehydrogenase (Quinone)
|
|
24 |
|
Glucose / Energy Metabolism
|
307 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
25 |
|
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway
|
32 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
26 |
|
Regulation of activated PAK-2p34 by proteasome mediated degradation
|
978 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
27 |
|
Estrogen metabolism
|
23 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
28 |
|
Metapathway biotransformation Phase I and II
|
296 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|
29 |
|
NRF2-ARE regulation
|
23 |
0.499 |
Genes names |
- NAD(P)H Quinone Dehydrogenase 1
|
|